Financial Summary (All financials)
| In millions, except per share items | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 |
| Revenues | 29.2 | 27.4 | 26.7 | 27.9 | 25.3 | 24.4 | 16.9 | 1.1 |
| Revenue growth | 6.6% | 2.5% | -4.3% | 10.3% | 3.8% | 44.3% | 1389.7% | -99.2% |
| Cost of goods sold | 13.3 | 13.4 | 13.4 | 13.7 | 14.9 | 14.5 | 16.2 | 16.9 |
| Gross profit | 15.9 | 14.0 | 13.3 | 14.2 | 10.4 | 9.9 | 0.7 | -15.8 |
| Gross margin | 54.5% | 51.1% | 49.9% | 51.0% | 41.0% | 40.7% | 4.3% | -1391.6% |
| Selling, general and administrative | | | | | 4.2 | 4.1 | 4.2 | 4.4 |
| Sales and marketing | 0.2 | 0.2 | 0.4 | 0.2 | | | | |
| Research and development | 1.0 | 0.8 | 0.7 | 0.6 | | | | |
| General and administrative | 2.3 | 2.1 | 2.5 | 3.4 | | | | |
| EBIT | 12.3 | 10.9 | 9.7 | 10.0 | 6.2 | 5.8 | -18.1 | -20.1 |
| EBIT margin | 42.2% | 39.9% | 36.3% | 36.0% | 24.5% | 23.7% | -107.3% | -1776.7% |
| Pre-tax income | 9.2 | 6.4 | 4.8 | 1.6 | -16.6 | -7.7 | -23.9 | -31.4 |
| Income taxes | -1.8 | -5.1 | -0.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 |
| Tax rate | | | | 2.7% | 0.0% | 0.0% | 0.0% | |
| Net income | 9.2 | 9.3 | 3.0 | 0.0 | -17.7 | -10.6 | -26.1 | -34.9 |
| Net margin | 31.7% | 33.9% | 11.4% | 0.1% | -69.8% | -43.3% | -154.3% | -3080.3% |
| |
| Diluted EPS | $0.31 | $0.31 | $0.14 | $0.00 | ($1.33) | ($0.80) | ($1.97) | ($2.64) |
| Shares outstanding (diluted) | 30.1 | 30.1 | 21.1 | 13.3 | 13.3 | 13.3 | 13.3 | 13.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|